SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-000670
Filing Date
2014-04-21
Accepted
2014-04-21 11:23:40
Documents
11
Period of Report
2014-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K lorus6k.htm 6-K 13600
2 NEWS RELEASE DATED MARCH 18, 2014 - COO DEPARTURE ex991.htm EX-99.1 6391
3 GRAPHIC image_001.jpg GRAPHIC 4031
4 PRESS RELEASE DATED MARCH 26TH, 2014 - $17M OVERNIGHT MARKETED FINANCING ex992.htm EX-99.2 9648
5 GRAPHIC image_002.jpg GRAPHIC 65946
6 PRESS RELEASE DATED MARCH 27TH, 2014 - MARKETED FINANCING TO $25M ex993.htm EX-99.3 9449
7 PRESS RELEASE DATED APRIL 4TH, 2014 - AACR MEETING 2014 ex994.htm EX-99.4 10822
8 PRESS RELEASE DATED APRIL 8TH, 2014 - LOR-253 DATA ex995.htm EX-99.5 10186
9 PRESS RELEASE DATED APRIL 8TH, 2014 - CONFERENCE CALL ex996.htm EX-99.6 8499
10 PRESS RELEASE DATED APRIL 10TH, 2014 - COMPLETION OF OFFERING ex997.htm EX-99.7 11203
11 PRESS RELEASE DATED APRIL 10TH, 2014 - THIRD QUARTER 2014 RESULTS ex998.htm EX-99.8 42844
  Complete submission text file 0001279569-14-000670.txt   220621
Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7
Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7 416-798-1200
LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 14773100
SIC: 2836 Biological Products, (No Diagnostic Substances)